↓ Skip to main content

Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir

Overview of attention for article published in Drug Design, Development and Therapy, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir
Published in
Drug Design, Development and Therapy, March 2022
DOI 10.2147/dddt.s356951
Pubmed ID
Authors

Santiago Moreno, Bernardino Alcázar, Carlos Dueñas, Juan González del Castillo, Julián Olalla, Antonio Antela

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 16%
Other 2 8%
Student > Doctoral Student 2 8%
Researcher 2 8%
Student > Master 2 8%
Other 1 4%
Unknown 12 48%
Readers by discipline Count As %
Medicine and Dentistry 2 8%
Environmental Science 2 8%
Agricultural and Biological Sciences 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Arts and Humanities 1 4%
Other 5 20%
Unknown 12 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2024.
All research outputs
#2,214,271
of 26,166,431 outputs
Outputs from Drug Design, Development and Therapy
#108
of 2,294 outputs
Outputs of similar age
#51,982
of 455,602 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 38 outputs
Altmetric has tracked 26,166,431 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,294 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.